Cost-Effectiveness Assessment of Monitoring Abiraterone Levels in Metastatic Castration-Resistant Prostate Cancer Patients

This study aims to investigate the cost-effectiveness of monitoring abiraterone Cmin in patients with mCRPC.

Source: Value in Health - September 10, 2020 Category: International Medicine & Public Health Authors: Renske M.T. ten Ham, Merel van Nuland, Rick A. Vreman, Laurens G. de Graaf, Hilde Rosing, Andr é M. Bergman, Alwin D.R. Huitema, Jos H. Beijnen, Anke M. Hövels Source Type: research